WTO

Christine LAGARDE asked to change EU “opt-out” of 30 August 2003 decision regarding imports of generic medicines manufactured under a compulsory license

Posted on by KEI Staff

Original page: http://www.cptech.org/ip/health/tamiflu/christinelagarde.html Christine LAGARDE asked to change EU “opt-out” of 30 August 2003 decision regarding imports of generic medicines manufactured under a compulsory license To: Christine LAGARDE, Ministre déléguée au Commerce extérieur, France From: Manon Ress and James Love,… Continue Reading →

CPTech Letter to EC Director General of Trade Peter Mandelson

Posted on by KEI Staff

Original page: http://www.cptech.org/ip/health/tamiflu/cptech-mandelson10192005.html CPTech Letter to EC Director General of Trade Peter Mandelson 19th October 2005 Commissioner Mandelson EUROPEAN COMMISSION DG Trade 200 rue de la Loi B-1049 BRUSSELS Dear Commissioner Mandelson TRIPS Agreement and Avian Influenza We ask the… Continue Reading →

CPTech Letter to USTR Portman Regarding US Position on WTO Opt-Out of Compulsory Licensing Mechanism

Posted on by KEI Staff

Original page: http://www.cptech.org/ip/birdflu/ustr-birdflu.html 14 October 2005 Honorable Rob Portman United States Trade Representative 600 17th Street, N.W. Washington, DC 20508 Dear Ambassador Portman: We are writing to ask that the United States government address a mistake in trade policy that… Continue Reading →

Senator Ted Kennedy’s 2005 remarks in the U.S. Senate on the Doha Declaration on TRIPS and Public Health

Posted on by James Love

February 16, 2005 109th Congress, 1st Session Issue: Vol. 151, No. 17 — Daily Edition [Pages S1498-S1499] From the Congressional Record Online through the Government Publishing Office [www.gpo.gov] THE DOHA DECLARATION AND THE TRADE PROMOTION AUTHORITY ACT OF 2002 Mr.… Continue Reading →

CPTech Statement on WTO Deal on Exports of Medicines

Posted on by KEI Staff

Original page: http://www.cptech.org/ip/wto/p6/cptech08302003.html CPTech Statement on WTO Deal on Exports of Medicines August 30, 2003 “Today’s decision on the implementation of paragraph 6 of the Doha Declaration on TRIPS and Public Health puts the WTO into unchartered waters. The WTO… Continue Reading →

USTR Zoellick Letter to TACD IP Group Regarding WTO Compulsory Licensing Mechanism

Posted on by KEI Staff

Original page: http://www.cptech.org/ip/wto/p6/zoellick02102003.doc RECEIVED 24 FEB 2003 Executive Office of the President The United States Trade Representative Washington, DC 20508 February 10, 2003 Mr. James Love Co-Chair TACD IP-workinggroup TACD Secretariat 24 Highbury Crescent UK-London N5 1RXDear Mr. Love, Thank… Continue Reading →

EC Pascal Lamy Letter in Response to TACD regarding WTO Export Issue

Posted on by KEI Staff

Original: Page 1 – http://www.cptech.org/ip/health/eu/lamy2tacd20mar2002-p1.jpg Page 2 – http://www.cptech.org/ip/health/eu/lamy2tacd20mar2002-p2.jpg Note by James Love on April 1, 2002 via IP-Health email list regarding the letter below (archived link of the note here): This these are scans of Pascal Lamy’s March 20… Continue Reading →